Global Study from 3M Reveals – Science is Underappreciated
Science needs a champion. This is the conclusion 3M has come to following analysis from its first annual State of Science Index (SOSI), a global study exposing the general population’s attitudes towards science. At first glance, results from the study suggest sentiment towards science is overwhelmingly positive: half of respondents believe flying cars will become a reality within their lifetime and 87 percent characterize science as fascinating, not boring.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180306005678/en/
3M State of Science Index (Graphic: Business Wire)
However, upon further inspection, the survey reveals many people are unaware of the impact science has on their lives: almost 40 percent believe everyday life would not be much different if science did not exist (38 percent). A pattern of skepticism around science also prevails. The study found that almost one-third (32 percent) of the global population is skeptical of science, and 20 percent distrust scientists.
The independent, 14-country State of Science Index was commissioned by 3M (MMM), a global science and innovation company, and conducted by Ipsos, a global market research firm. The study explores the image of science around the world. Respondents were asked about their knowledge, understanding and appreciation of science, as well as questions about the image and future of science.
“We set out to get a pulse on what the general public thinks and feels about science and its impact on the world. Is science valued and trusted, or is it unappreciated?” said John Banovetz, chief technology officer at 3M. “These rich insights put a spotlight on science and reveal differences in attitudes between emerging and developed countries, men and women, and even cross-generation. The world is becoming more technologically advanced every day and science is driving those technology breakthroughs. We hope that by making the survey data available and accessible, we will inspire science champions and future scientists everywhere and bring a greater appreciation of science to the world.”
Key insights from the study
- For many, science is seen as being accessible only to “geniuses.” The study found more than one-third of people are intimidated by science, with 36 percent agreeing only geniuses can have a career in science.
- More work needs to be done to address the gender gap in science. Women are less engaged with and interested in science than men. They are more likely than men to say they know nothing about science (21 percent vs. 15 percent) and are significantly less likely to believe a career in engineering would be satisfying (9 percent vs. 25 percent). Women, however, are more interested than men in medicine (20 percent vs. 14 percent) and life science (15 percent vs. 10 percent).
- Science is appreciated more on the macro, societal level, than the micro, everyday level. Significantly more people believe science is very important to society in general (63 percent) than it is to everyday life (46 percent).
- People have great expectations for science. About three in four believe science can solve different global challenges inspired by the United Nations’ Sustainable Development Goals. Globally, people are optimistic that science can solve challenges related to access to affordable renewable energy (75 percent) and energy supply (74 percent). People are also turning to science to solve challenges related to disease treatment (75 percent), clean water and sanitation (73 percent) and Internet access (73 percent). But confidence in science to solve the following global challenges is much lower: climate change (46 percent), hunger (45 percent), aging population (41 percent) and unemployment (33 percent).
- People are largely unconscious of science and its impact on their lives. The majority (66 percent) think about the impact science has on their everyday lives “a little to never.”
- Nearly half the population wishes they had pursued a career in science. While a small majority of people (54 percent) have no regrets about pursuing a non-science career, nearly half wish they had chosen a career in science (46 percent).
- Science skeptics and science supporters are unified with respect to their kids and the next generation. When it comes to the next generation, science skeptics and non-skeptics are surprisingly aligned: 82 percent would encourage kids to pursue a science career and 92 percent of parents want their kids to know more about science; at the same time, 33 percent think students need a better understanding of how science improves the world to inspire them to pursue a career in it.
Full study data, including individual country breakdowns across 14 countries and the ability for individuals to explore the data further can be found at 3M.com/scienceindex.
Optimism for the future of science
Despite skepticism and a general misunderstanding about science, excitement for the future of scientific advancements is high. When asked about what they believe science will achieve in their lifetime, the top responses included robots in every workplace (64 percent), robots in every home (55 percent) and flying cars (51 percent). Additionally, there were expectations for undersea living (41 percent) and inhabiting Mars (35 percent), all within our lifetime.
Overall, the study found that emerging countries are more optimistic about future scientific advancements than respondents from developed countries. Emerging countries are much more likely to think flying cars (58 percent emerging vs. 43 percent developed) and controlling the weather (43 percent vs. 22 percent) would be possible in their lifetime.
“Even great scientific advancements are the product of multiple discoveries over years of work,” said Banovetz. “If students think that only geniuses can have a career in science and people remain indifferent to science, how can we thrive as a society and continue to innovate? To secure a better future we need to be vigilant about helping people understand all the incredible opportunities and innovations science has brought us, as well as the dedication, rigor and investment it takes to achieve those results.”
3M’s commitment to science
Recognizing the need to champion science, 3M has appointed Dr. Jayshree Seth as the first-ever 3M chief science advocate. Dr. Seth will be an ambassador that fosters and contributes to dialogues on the image of science and the importance it plays in improving lives around the world.
An accomplished scientist with a PhD in chemical engineering and 60 patents to her name, Dr. Seth has earned the distinguished title of corporate scientist – the highest position within the technical community at 3M. In addition to her accomplishments in scientific innovation, Dr. Seth is passionate about mentoring young scientists as well as other 3M employees.
“As a student, at times I struggled with science subjects myself. I was lucky to have inspirational teachers and an encouraging family that truly believed in the benefits of science,” said Dr. Seth. “In my role as chief science advocate, I’ll raise awareness and break down barriers to the appreciation and excitement of science. I want people to know you don’t need to be a genius to be a scientist. I want people to understand how science improves lives and drives the innovations we rely on every minute of every day. And, ultimately, I want to be a part of the solution that creates a new generation of science advocates. This is particularly important because by 2050 the world population is anticipated to grow from 7 billion to 9 billion, and the economy is expected to quadruple.1 We need science to solve the problems and seize the opportunities that come from that growth, such as increased energy use, water scarcity, transportation congestion and air pollution.”
The appointment of Dr. Seth to the role of chief science advocate builds on 3M’s 40-year commitment to foster the next generation of scientists and improve lives. Across the United States and internationally, 3M provides substantial resources to support STEM initiatives.
In the United States, 3M’s 10-year commitment to the Discovery Education 3M Young Scientist Challenge, a premier science competition for middle school students, has connected aspiring young scientists with 3M mentors. Globally, 3Mgives, the company’s philanthropic arm, has supported dozens of local markets through programs such as a partnership with “Let’s Talk Science” in Canada for over 10 years, a Mobile Science Lab Initiative in India, a five-year Science Challenge including teacher training and a student competition in Brazil, as well as support of First Robotics teams and WorldSkills competitions around the world.
In 2018, 3Mgives will be making a significant investment in international STEM initiatives. For example, the company will participate in a new STEMania program in Saudi Arabia to promote gender equity and encourage young females in elementary and intermediate grades to pursue STEM careers.
Ipsos conducted the study of 14,036 adults across 14 countries between June 14, 2017 and August 26, 2017. The survey was fielded through a combination of online and offline interviews. Approximately 1,000 people aged 18+ were surveyed in each country. Countries included in the study: Brazil, Canada, China, France, Germany, India, Japan, Mexico, Poland, Kingdom of Saudi Arabia, Singapore, South Africa, United Kingdom and the United States. The sample for each country was nationally representative based on age, gender, region, and race/ethnicity (where applicable). At the 95 percent confidence level, the margin of error for the 14-country global total is +/- 0.83 percentage points. Emerging and developed countries were grouped in the following way:
- Developed: Canada, France, Germany, Japan, Singapore, United Kingdom, United States
- Emerging: Brazil, China, India, Mexico, Poland, Kingdom of Saudi Arabia, South Africa
At 3M, we apply science in collaborative ways to improve lives daily. With $32 billion in sales, our 91,000 employees connect with customers all around the world. Learn more about 3M’s creative solutions to the world’s problems at www.3M.com or on Twitter @3M or @3MNews.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00 | Pressemelding
Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines
Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10 | Pressemelding
Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest
Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13 | Pressemelding
Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,
Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00 | Pressemelding
Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With
Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41 | Pressemelding
Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00 | Pressemelding
Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i